Healthcare -
Biotechnology - NASDAQ - US
$ 4.975
-2.26 %
$ 216 M
Market Cap
-2.43
P/E
ABEO - CAPITAL EXPENDITURES
Capital Expenditures ABEO - Abeona Therapeutics Inc.
-331 K
LAST VALUE
71.76%
2 YEAR CAGR
55.74%
5 YEAR CAGR
-66.68%
10 YEAR CAGR